MGTX
MeiraGTx Holdings PLC
NASDAQ: MGTX · HEALTHCARE · BIOTECHNOLOGY
$9.71
-0.46% today
Updated 2026-10-29
Market cap
$884.56M
P/E ratio
10.71
P/S ratio
2.23x
EPS (TTM)
$0.86
Dividend yield
—
52W range
$7 – $15
Volume
0.9M
WallStSmart proprietary scores
61
out of 100
Grade: C+
Hold
Investment rating
8.0
Growth
A6.0
Quality
B9.5
Profitability
A+6.7
Valuation
B5/9
Piotroski F-Score
Moderate
-5.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$27.75
+185.94%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 36.64% — strong efficiency
+ Revenue growth 8,609.00% QoQ
Risks
- Altman Z -5.87 — distress zone
- Negative free cash flow $-40.55M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $15.92M | $14.02M | $33.28M | $81.39M | $397.50M |
| Net income | $-129.62M | $-84.03M | $-147.79M | $-114.20M | $160.72M |
| EPS | — | — | — | — | $0.86 |
| Free cash flow | $-118.06M | $-125.54M | $-109.45M | $-50.19M | $-40.55M |
| Profit margin | -814.16% | -599.46% | -444.10% | -140.31% | 19.90% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-10-06 | NAYLOR, STUART | S | 27,659 | $10.64 |
| 2026-09-23 | SEBULSKY, ALAN | Buy | 100,000 | — |
| 2026-08-18 | FORBES, ALEXANDRIA | S | 62,000 | $13.86 |
Peer comparison
Smart narrative
MeiraGTx Holdings PLC trades at $9.71. representing a P/E of 10.71x trailing earnings. Our Smart Value Score of 61/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -5.87, it sits in the distress. TTM revenue stands at $397.50M. with profit margins at 19.90%.
Frequently asked questions
What is MeiraGTx Holdings PLC's stock price?
MeiraGTx Holdings PLC (MGTX) trades at $9.71, on a P/E of 10.7x and a P/S of 2.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is MeiraGTx Holdings PLC overvalued?
MeiraGTx Holdings PLC carries a Smart Value Score of 61/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of MeiraGTx Holdings PLC (MGTX)?
The 12-month analyst consensus target is $27.75, about 185.9% above the current $9.71. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is MeiraGTx Holdings PLC's revenue?
MeiraGTx Holdings PLC's trailing twelve-month revenue is $397.50M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
MeiraGTx Holdings PLC's Altman Z-Score is -5.87, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.23x
ROE36.64%
Beta1.35
50D MA$12.18
200D MA$10.26
Shares out0.10B
Float0.05B
Short ratio—
Avg volume0.9M
Performance
1 week-4.67%
1 month-15.39%
3 months-19.10%
YTD+18.24%
1 year+1.51%
3 years—
5 years—